Last close · 16 Oct 2026
Rs 128.65 -0.96%
Quarterly · Q4 FY2023 – Q4 FY2026
BF Biosciences Limited (BFBIO) quarterly cash flow statement
| Rs mn | TTM to Jun 2026 | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||||
| Profit (cash-flow starting line, as reported) | — | — | 202.4 | 448.7 | 159.5 | 126.8 | 124.5 | 80.5 | 115.3 | |||||
| Depreciation & amortisation | — | — | 69.4 | 68.7 | 67.4 | 65.1 | 80.8 | 32.2 | 15.5 | |||||
| Net cash from operating activities | — | — | (831.5) | 592.2 | 24.2 | 521.2 | (428.3) | 169.3 | 20.3 | |||||
| Investing activities | ||||||||||||||
| Capital expenditure | — | — | (142.5) | (176.5) | (64.3) | (130.6) | (14.7) | (92.0) | (97.3) | |||||
| Net cash from investing activities | — | — | 667.8 | (238.8) | (163.9) | (283.8) | 767.9 | (1,813.9) | (100.3) | |||||
| Financing activities | ||||||||||||||
| Borrowings raised / (repaid) | — | — | (72.0) | (149.7) | (71.3) | (190.8) | (29.7) | (95.5) | (26.6) | |||||
| Net cash from financing activities | — | — | (72.0) | (149.7) | (71.3) | (190.8) | (29.7) | 107.7 | 1,625.4 | |||||
| Net change in cash | — | — | (235.7) | 203.7 | (211.0) | 46.7 | 309.9 | (1,536.9) | 1,545.4 | |||||
| Key figures | ||||||||||||||
| Free cash flow (operating cash flow − capex) | — | — | (974.0) | 415.7 | (40.1) | 390.6 | (443.0) | 77.3 | (76.9) | |||||
| Rs mn | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | |||||||||||||
| Profit (cash-flow starting line, as reported) | — | +62.5% | +457.1% | +38.4% | — | -22.6% | +53.7% | +14.4% | |||||
| Depreciation & amortisation | — | -14.1% | +113.6% | +335.7% | +503.3% | +860.1% | +284.0% | +81.4% | |||||
| Net cash from operating activities | — | — | +249.8% | +18.8% | — | -264.6% | +181.1% | -90.2% | |||||
| Investing activities | |||||||||||||
| Capital expenditure | — | +871.3% | +91.7% | -33.9% | +254.4% | -68.5% | +169.1% | +281.8% | |||||
| Net cash from investing activities | — | -13.0% | — | — | — | — | — | -218.4% | |||||
| Financing activities | |||||||||||||
| Borrowings raised / (repaid) | — | — | — | — | — | — | — | — | |||||
| Net cash from financing activities | — | — | -239.0% | -104.4% | — | — | — | — | |||||
| Net change in cash | — | -176.1% | — | -113.7% | — | +87.0% | — | +533.4% | |||||
| Key figures | |||||||||||||
| Free cash flow (operating cash flow − capex) | — | — | +438.1% | — | — | -307.4% | +196.9% | -142.1% | |||||
Change against the same quarter a year earlier; shown when the earlier figure is positive.
Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. TTM = the latest four quarters added together. Updated 16 Oct 2026.
All reported line items 52
| Rs mn | Q4 FY2026 Apr – Jun 2026 | Q3 FY2026 Jan – Mar 2026 | Q2 FY2026 Oct – Dec 2025 | Q1 FY2026 Jul – Sep 2025 | Q4 FY2025 Apr – Jun 2025 | Q3 FY2025 Jan – Mar 2025 | Q2 FY2025 Oct – Dec 2024 | Q1 FY2025 Jul – Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Profit/(Loss) - Starting Line - Cash Flow | — | 202.4 | 448.7 | 159.5 | 126.8 | 124.5 | 80.5 | 115.3 |
| Non-cash Items & Reconciliation Adjustments - Cash Flow | — | 115.6 | 1.9 | 190.6 | 121.5 | 130.5 | 104.4 | 130.4 |
| Income Tax Expense - Cash Flow - to Reconcile | — | — | (108.4) | 108.4 | 71.6 | 75.2 | 60.3 | 66.3 |
| Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile | — | 45.3 | 50.0 | 23.0 | 17.0 | (16.1) | 4.0 | 16.0 |
| Financial Income/(Expense) - Cash Flow - to Reconcile | — | 22.5 | 24.4 | 24.7 | (75.2) | 29.7 | 39.8 | 34.7 |
| Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile | — | 69.4 | 68.7 | 67.4 | 65.1 | 80.8 | 32.2 | 15.5 |
| Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile | — | 69.0 | 68.3 | 67.0 | 64.6 | 80.3 | 31.8 | 15.3 |
| Amortization - Intangible Assets & Deferred Charges - Cash Flow - to Reconcile | — | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | 0.4 | 0.1 |
| Assets Sale - Gain/(Loss) - Cash Flow - to Reconcile | — | (37.1) | (15.4) | (3.1) | 0.8 | (28.5) | (0.1) | 0.0 |
| Financial Assets - Unrealized Gain/(Loss) - Cash Flow - to Reconcile | — | 15.4 | (17.5) | (29.8) | 42.2 | (10.7) | (31.7) | (2.0) |
| Income Taxes - Paid/(Reimbursed) - Cash Flow | — | 76.2 | 73.5 | 82.1 | 71.6 | 30.1 | 163.3 | 14.0 |
| Interest Paid - Cash | — | 12.9 | 22.8 | 23.8 | 14.0 | 26.3 | 36.8 | 35.1 |
| Interest & Dividends - Received - Total - Cash Flow | — | 0.6 | 3.5 | 1.6 | 76.5 | 0.4 | 17.8 | 0.4 |
| Cash Flow from Operating Activities before Changes in Working Capital | — | 229.4 | 357.8 | 245.9 | 239.2 | 198.9 | 2.6 | 197.0 |
| Working Capital - Increase/(Decrease) - Cash Flow | — | (1,060.9) | 234.4 | (221.7) | 282.0 | (627.2) | 166.7 | (176.7) |
| Accounts Receivables - Decrease/(Increase) - Cash Flow | — | (26.5) | (28.3) | (503.0) | 225.8 | (131.9) | 162.9 | (307.3) |
| Inventories - Decrease/(Increase) - Cash Flow | — | (65.0) | (923.2) | (49.5) | 96.2 | (353.3) | (347.1) | (242.2) |
| Other Assets - Decrease/(Increase) - Cash Flow | — | 105.8 | (82.2) | 41.5 | (17.0) | (36.6) | 246.0 | (117.7) |
| Accounts Payable and Accrued Expenses - Increase/(Decrease) - Cash Flow | — | (965.8) | 1,166.7 | 274.0 | (13.1) | (89.2) | 100.2 | 474.6 |
| Other Liabilities - Increase/(Decrease) -Total - Cash Flow | — | (109.5) | 101.4 | 15.3 | (9.8) | (16.2) | 4.7 | 16.0 |
| Net Cash Flow from Operating Activities | — | (831.5) | 592.2 | 24.2 | 521.2 | (428.3) | 169.3 | 20.3 |
| Capital Expenditures - Net - Cash Flow | — | 138.9 | 173.6 | 64.3 | 123.7 | 12.8 | 91.9 | 97.3 |
| Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow | — | 138.9 | 173.6 | 64.3 | 128.8 | 7.7 | 91.9 | 97.3 |
| Property, Plant & Equipment - Purchased - Cash Flow | — | 142.5 | 176.5 | 64.3 | 130.6 | 9.6 | 92.0 | 97.3 |
| Property, Plant & Equipment Sold - Cash Flow | — | 3.6 | 2.8 | 0.0 | 1.8 | 1.8 | 0.2 | — |
| Intangible Assets - Purchased/(Sold) - Net - Total - Cash Flow | — | — | — | — | (5.1) | 5.1 | — | — |
| Intangible Assets - Purchased/Acquired - Cash Flow | — | — | — | — | — | 5.1 | — | — |
| Intangible Assets - Net - Cash Flow | — | — | — | — | (5.1) | — | — | — |
| Capital Expenditures - Total | — | 142.5 | 176.5 | 64.3 | 130.6 | 14.7 | 92.0 | 97.3 |
| Investments excluding Loans - Decrease/(Increase) - Cash Flow | — | 805.9 | 0.8 | (99.6) | (156.1) | 780.7 | (1,725.0) | — |
| Investment Securities - Unclassified - Sold/(Purchased) - Net - Total - Cash Flow | — | 805.9 | 0.8 | (99.6) | (156.1) | 780.7 | (1,725.0) | — |
| Other Investing Cash Flow - Decrease/(Increase) | — | 0.8 | (66.0) | — | (4.0) | (0.0) | 3.0 | (3.0) |
| Net Cash Flow from Investing Activities | — | 667.8 | (238.8) | (163.9) | (283.8) | 767.9 | (1,813.9) | (100.3) |
| Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow | — | (72.0) | (149.7) | (71.3) | (190.8) | (29.7) | (95.5) | (26.6) |
| Debt - Issued/Reduced - Long-Term - Cash Flow | — | (72.0) | (149.7) | (71.3) | (190.8) | (29.7) | (95.5) | (26.6) |
| Debt - Issued - Long-Term - Cash Flow | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 66.8 | 26.8 |
| Debt - Reduced - Long-Term - Cash Flow | — | 72.0 | 149.7 | 71.3 | 190.8 | 29.7 | 162.3 | 53.4 |
| Other Financing Cash Flow - Increase/(Decrease) | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 203.2 | 1,652.0 |
| Net Cash Flow from Financing Activities | — | (72.0) | (149.7) | (71.3) | (190.8) | (29.7) | 107.7 | 1,625.4 |
| Net Change in Cash - Total | — | (235.7) | 203.7 | (211.0) | 46.7 | 309.9 | (1,536.9) | 1,545.4 |
| Net Cash from Continuing Operations | — | (235.7) | 203.7 | (211.0) | 46.7 | 309.9 | (1,536.9) | 1,545.4 |
| Net Cash - Beginning Balance | — | 307.7 | 104.1 | 315.1 | 268.4 | (41.4) | 1,495.5 | (49.9) |
| Net Cash - Ending Balance | — | 72.1 | 307.7 | 104.1 | 315.1 | 268.4 | (41.4) | 1,495.5 |
| Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental | — | 76.2 | 73.5 | 82.1 | 71.6 | 30.1 | 163.3 | 14.0 |
| Interest Paid - Cash Flow - Supplemental | — | 12.9 | 22.8 | 23.8 | 14.0 | 26.3 | 36.8 | 35.1 |
| Interest & Dividends - Received - Cash Flow - Supplemental | — | 0.6 | 3.5 | 1.6 | 76.5 | 0.4 | 17.8 | 0.4 |
| CF from Optg Activities before Change in WC & Int Payments | — | 242.4 | 380.6 | 269.7 | 253.3 | 225.2 | 39.4 | 232.1 |
| Contract Liabilities - Increase/(Decrease) - Cash Flow | — | (109.5) | 101.4 | 15.3 | (9.8) | (16.2) | 4.7 | 16.0 |
| Depreciation, Depletion & Amortization - Cash Flow | — | 69.4 | 68.7 | 67.4 | 65.1 | 80.8 | 32.2 | 15.5 |
| Free Cash Flow to Equity | — | (1,042.4) | 268.8 | (111.4) | 206.8 | (470.8) | (18.1) | (103.6) |
| Free Cash Flow Net of Dividends | — | (974.0) | 415.7 | (40.1) | 390.6 | (443.0) | 77.3 | (76.9) |
| Free Cash Flow | — | (974.0) | 415.7 | (40.1) | 390.6 | (443.0) | 77.3 | (76.9) |
Every line the company reported, in the original order and wording, without regrouping or signs changed.